Helping You Confidently Navigate the Shifting Market Landscape, Create and Communicate Value, and Optimize Access

A recent survey of 300 senior biopharmaceutical executives responsible for launching their organization’s first or second asset revealed that initiating investment and planning for market access strategy is their number one priority three years prior to launch. Whether you’re a multinational company with a history of blockbuster launches or a start-up with a promising pipeline, market access barriers – from pricing pressures to consolidation to the emergence of value framework assessments -- are changing the face of commercialization.

 

 

Defining Value in Today’s Complex Landscape

Demonstrating value and optimizing access requires a partner who understands every stakeholder’s unique definition of value and how those definitions and needs impact your brand throughout the product lifecycle. 

 

The Continuity and the Flexibility to Adapt to Shifting Needs

Our team can partner with you on a project basis, or we can bring continuity from optimizing early development to tailoring strategies for in-market products. We approach market access questions with decades of experience, cross-functional expertise and unparalleled stakeholder insight.

 

A Unique Approach to Navigating Value Assessments With a Single Partner 

Syneos Health Value & Access can simplify the complex landscape with a team purpose-built to ensure that all aspects of value demonstration aren’t just interconnected – they’re orchestrated to be optimized.

 

Optimizing Value At Every Stage Of Your Product’s Lifecycle

 

Click on the image to expand it

 

Real World Evidence 
Meeting Your Needs for Data From Real Life
The well-known standards of clinical evidence development are giving way to newly emerging, continuously evolving norms of real world evidence (RWE) development to meet the varying needs of stakeholders: payers, providers, patients and health technology assessment agencies, in addition to regulatory bodies. 
  
As subject matter experts and research practitioners, not just database curators or software developers, we identify the most appropriate solution to each opportunity you face. We select real world data sources and data collection technologies to fit your individual needs, rather than apply one-size-fits-all approaches driven by proprietary databases.

Our Real World Evidence experts offer:

  • Real World Research Design & Feasibility
  • Synthetic Controls for Single-Arm Trials 
  • Early Access Programs
  • Post-Marketing Safety Surveillance 
  • Comparative Effectiveness in Real World Use Value Access & Medical

 

Value Access and Medical
Mobilizing Teams to Provide Multidisciplinary Integration and Unparalleled Continuity
Our medical and sales field solutions cover the areas that are most important to your business including value access, therapeutic strategic solutions and contact centers. The shift in expectations for field teams has changed their composition, and the new varied bench of talent includes clinical educators, medical science liaisons, as well as reimbursement and access managers. We mobilize teams to meet new commercialization demands.

Our Value Access and Medical experts offer:

  • Account Management Teams
  • Field Reimbursement Specialists 
  • Clinical Educators
  • Medical Science Liaisons
  • Contact Centers 
  • Recruitment & Talent Acquisition

 

Consulting
Seasoned Industry Insiders Creating Innovative Solutions for You
Market access has never been more challenging, competitive, and complex. Our team offers you a full spectrum of custom consultations and services to help you navigate commercialization, maneuver the market access landscape, and maximize access for your brand globally. Powered by our unmatched cadre of industry leaders and innovators in commercial strategy, pricing, value, HEOR, policy, and access, we provide experienced, integrated solutions teams. 

Our Consulting experts offer:

  • Commercialization & Portfolio Strategy 
  • Value Proposition Development 
  • Pricing Strategy 
  • Market Access Strategy 
  • Economic Evidence 

 

Risk Management
Stakeholder-side Perspectives to Help Mitigate Your Risks
Experience within Congress, FDA, provider organizations, commercial payers, finance, the law, and public health has made our communicators, policy-shapers and subject-matter experts in healthcare policy. Through the lens of their experience, we develop powerful new approaches to gain and maintain acceptance for the price of your medicines throughout their lifecycles. We protect your reputation and mitigate your risk via an evidence-based approach, proactively building your stakeholders’ expectations about your medicine’s value... on the runway to approval and beyond. 

Our Risk Management experts offer:

  • Value Promotion and Protection 
  • Value Frameworks (ICER)
  • Public Policy Perspectives

 

Payer Communications & Access Marketing
Insights Fueling Effective Payer Communications and Access Marketing
To resonate powerfully with your audience, the words and images of your value narrative need to be crafted meticulously. Your stories must speak to audiences on their own terms, in their language, and where appropriate must balance convincing facts with compelling emotion. For you, an agency that understands payer customers as people first—a team that can connect insights, data, and trends to motivate behavior—can produce market-changing stories.

Our Payer Communications & Access Marketing experts offer:

  • Payer Marketing Communications 
  • Pull-through 
  • Medical Communications 
  • Market Research 
  • Digital & Social Media Strategy

 

To download our Syneos Health Value and Access brochure, please click here.

 

 

Perspectives: 
  • Value and Access
05.14.19